TECHNOLOGY
RFK Jr.'s hand-picked committee approves manufacture of peptides he uses
Ars TechnicaFriday, July 24, 2026 at 7:10 PM
RedScroll Brief

There's no human safety or efficacy data, but that no longer seems to matter.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
There's no human safety or efficacy data, but that no longer seems to matter.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
Ars Technica reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
Ars Technica published: RFK Jr.'s hand-picked committee approves manufacture of peptides he uses
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Jr and Hand-picked.
More on
Related stories
- Report: Trump mad RFK Jr. hasn’t cut more vaccines or proven autism link
Ars TechnicaTECHNOLOGY
- The quest to keep organs alive outside the body
MIT Technology ReviewTECHNOLOGY
- The Download: an organ transplant breakthrough, and homegrown Chinese chips
MIT Technology ReviewTECHNOLOGY
- Supercooled kidneys have been transplanted into pigs in a “landmark achievement”
MIT Technology ReviewTECHNOLOGY
- Audi has a new flagship designed with the US in mind: The 2027 Q9
Ars TechnicaTECHNOLOGY
- Reaction wheel failures leave Swift rescue mission spinning in orbit
Ars TechnicaTECHNOLOGY
Sources
Ars Technica — original reporting. RedScroll provides an extractive briefing only.